Investing-News.Com
Information for Investors

Market News

Analysis

Internet Search		Stock Search

SONUS PHARM INC, (SNUS) Stock Research Free Stock Rating

Company Profile

Sonus Pharmaceuticals, Inc. engages in the development of drugs for the treatment of cancer and related therapies by utilizing its TOCOSOL technology platform. TOCOSOL technology platform uses vitamin E oil and tocopherol derivatives to solubilize and stabilize drugs for formulation of therapeutic drugs for cancer. The companys primary product TOCOSOL Paclitaxel is an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer, and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and is headquartered in Bothell, Washington.

SONUS PHARM INC Related

SNUS: Summary for SONUS Pharmaceuticals, Inc. - Yahoo! Finance Get detailed information on SONUS Pharmaceuticals, Inc. ... SONUS PHARMACEUTICALS INC Financials EDGAR Online Financials(Sat, Aug 9) ...

OncoGenex Pharmaceuticals, Inc. - News Releases BOTHELL, Washington, January 27, 2003 - Sonus Pharmaceuticals, Inc. ... Gensia Sicor is a wholly-owned subsidiary of SICOR Inc. ( Nasdaq:SCRI), a leading pharm...

Sponsored Links:

Software Forces SONUS PHARM INC Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in SONUS PHARM INC buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on SONUS PHARM INC. This software is specially designed to give precision entry and exit points on SONUS PHARM INC, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When SONUS PHARM INC Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even SONUS PHARM INC, if they make the cut.
Click Here & Learn To Pick Winners In An Uncertain Market

Search for SONUS PHARM INC at Investing-News.Com

StreetInsider Alerts

Latest Headlines

ONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Costs Associa (EDGAR Online)

Sonus Pharmaceuticals' Stockholders Approve Business Combination With OncoGenex Technologies (GlobeNewswire)

Sonus Pharmaceuticals Sets Date of Special Shareholders' Meeting (GlobeNewswire)

SONUS PHARMACEUTICALS INC Financials (EDGAR Online Financials)

SONUS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)

Sonus Pharmaceuticals Signs Exclusive In-Licensing Agreement With Bayer Healthcare for Caspase Activator Compounds (GlobeNewswire)

SONUS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)

SONUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)

Buy Out or Sell Out? (at Motley Fool)

SONUS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Ri (EDGAR Online)

Place Our Content On Your Site!